original-research-articleBortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease
Under an Elsevier user license
open archive
Keywords
antibodies
bortezomib
enzyme replacement therapy
glycogen storage disease type II
immune modulation
Cited by (0)
© 2013, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics